Natco Pharma Ltd.

Natco Pharma is currently trading at Rs. 417.50, up by 18.30 points or 4.58% from its previous closing of Rs. 399.20 on the BSE.

The scrip opened at Rs. 405.25 and has touched a high and low of Rs. 425.20 and Rs. 405.25 respectively. So far 1,72,000 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 623.60 on 05-Jan-2016 and a 52 week low of Rs. 365.79 on 28-Apr-2015.

Last one week high and low of the scrip stood at Rs. 438.80 and Rs. 390.00 respectively. The current market cap of the company is Rs. 7,263.00 crore.

The promoters holding in the company stood at 51.31% while Institutions and Non-Institutions held 26.41% and 22.28% respectively.

Natco Pharma has received its board's approval for the sale of Save Mart Pharmacy Stores located in USA, which is a non-core business of the Company. The Save Mart Pharmacy Stores is being owned by Natco Pharma Inc, a wholly owned subsidiary of the Company.

Natco Pharma is engaged in developing, manufacturing and marketing finished dosage formulations (FDF) and active pharmaceutical ingredients (APIs). Its operating segments include active pharmaceuticals ingredient, finished dosage formulations, job works, pharmacy and others.